International journal of clinical practice
-
Int. J. Clin. Pract. · Jan 2008
Randomized Controlled Trial Multicenter StudyEffects of oxybutynin transdermal system on health-related quality of life and safety in men with overactive bladder and prostate conditions.
Overactive bladder (OAB) is common in men and may exist concomitantly with benign prostatic hyperplasia (BPH) and obstruction. We present a subanalysis of results from men with OAB in a 6-month, open-label study of treatment with the oxybutynin transdermal system (OXY-TDS). Broad entry criteria were incorporated to yield a clinically representative population. ⋯ Oxybutynin transdermal system treatment of men with OAB was effective and well tolerated, regardless of history of prostate condition.